Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rigas Kalaitzidis

Showing results (1-10 of 39) with videos related to

Pageof 4
Sort By:
World Journal of Radiology|July 10, 2024
Navigating nephrotoxic waters: A comprehensive overview of contrast-induced acute kidney injury preventionPanagiotis Theofilis, Rigas Kalaitzidis
Journal of Clinical Hypertension (Greenwich, Conn.)|November 3, 2009
Pathogenesis and treatment of microalbuminuria in patients with diabetes: the road aheadRigas Kalaitzidis, George Bakris
Diabetes, Obesity & Metabolism|June 13, 2009
Management of hypertension in patients with diabetes: the place of angiotensin-II receptor blockersRigas Kalaitzidis, George Bakris
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|December 17, 2008
Should nephrologists use beta-blockers? A perspectiveRigas Kalaitzidis, George Bakris
Postgraduate Medicine|April 1, 2009
Are renin-angiotensin-aldosterone system blockers distinguishable based on cardiovascular and renal outcomes in nephropathy?Rigas Kalaitzidis, George Bakris
Journal of Hypertension. Supplement : Official Journal of the International Society of Hypertension|July 10, 2009
Effects of angiotensin II receptor blockers on diabetic nephropathyRigas Kalaitzidis, George L Bakris
Journal of Clinical Hypertension (Greenwich, Conn.)|July 9, 2009
Lower blood pressure goals for cardiovascular and renal risk reduction: are they defensible?Rigas Kalaitzidis, George L Bakris
Journal of Clinical Hypertension (Greenwich, Conn.)|October 9, 2018
Arterial damage and cognitive impairment in patients with chronic kidney diseaseDespina Karasavvidou, Rigas Kalaitzidis, Moses Elisaf
Journal of Pediatric Urology|October 9, 2019
An update on renal scarring after urinary tract infection in children: what are the risk factors?Chrysoula Kosmeri, Rigas Kalaitzidis, Ekaterini Siomou
American Journal of Nephrology|September 10, 2009
Predictors of hyperkalemia risk following hypertension control with aldosterone blockadeNitin Khosla, Rigas Kalaitzidis, George L Bakris
Pageof 4

Showing results (1-10 of 39) with videos related to

Sort By:
Pageof 4
World Journal of Radiology|July 10, 2024
Navigating nephrotoxic waters: A comprehensive overview of contrast-induced acute kidney injury preventionPanagiotis Theofilis, Rigas Kalaitzidis
Journal of Clinical Hypertension (Greenwich, Conn.)|November 3, 2009
Pathogenesis and treatment of microalbuminuria in patients with diabetes: the road aheadRigas Kalaitzidis, George Bakris
Diabetes, Obesity & Metabolism|June 13, 2009
Management of hypertension in patients with diabetes: the place of angiotensin-II receptor blockersRigas Kalaitzidis, George Bakris
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|December 17, 2008
Should nephrologists use beta-blockers? A perspectiveRigas Kalaitzidis, George Bakris
Postgraduate Medicine|April 1, 2009
Are renin-angiotensin-aldosterone system blockers distinguishable based on cardiovascular and renal outcomes in nephropathy?Rigas Kalaitzidis, George Bakris
Journal of Hypertension. Supplement : Official Journal of the International Society of Hypertension|July 10, 2009
Effects of angiotensin II receptor blockers on diabetic nephropathyRigas Kalaitzidis, George L Bakris
Journal of Clinical Hypertension (Greenwich, Conn.)|July 9, 2009
Lower blood pressure goals for cardiovascular and renal risk reduction: are they defensible?Rigas Kalaitzidis, George L Bakris
Journal of Clinical Hypertension (Greenwich, Conn.)|October 9, 2018
Arterial damage and cognitive impairment in patients with chronic kidney diseaseDespina Karasavvidou, Rigas Kalaitzidis, Moses Elisaf
Journal of Pediatric Urology|October 9, 2019
An update on renal scarring after urinary tract infection in children: what are the risk factors?Chrysoula Kosmeri, Rigas Kalaitzidis, Ekaterini Siomou
American Journal of Nephrology|September 10, 2009
Predictors of hyperkalemia risk following hypertension control with aldosterone blockadeNitin Khosla, Rigas Kalaitzidis, George L Bakris
Pageof 4